CurAccel is a minority, women-owned, Contract Research Organization (CRO). We are comprised of experts from the biotechnology, pharmaceutical, healthcare, clinical research organization, and site management organization industries.
Our portfolio of services include Phase I-III clinical trials for a wide array of therapeutic indications. From our inception in 2012, we have broadened our expertise our global presence across Asia/Pacific, Europe, and South America. giving our clients access to diverse patient populations, economized study execution, and high-quality clinical research services worldwide.